1. C-erbB2/HER2 in Human Gliomas, Medulloblastomas, and Meningiomas
   Ingunn Syversen Waage et al, 2013, International Journal of Surgical Pathology CrossRef
2. C3G downregulation induces the acquisition of a mesenchymal phenotype that enhances aggressiveness of glioblastoma cells
   Sara Manzano et al, 2021, Cell Death & Disease CrossRef
3. Advances in HER2-Targeted Therapies: From monoclonal antibodies to dual inhibitors developments in cancer treatment
   Meduri Bhagyalalitha et al, 2024, Bioorganic Chemistry CrossRef
4. Small Molecule Tyrosine Kinase Inhibitors of ErbB2/HER2/Neu in the Treatment of Aggressive Breast Cancer
   Richard Schroeder et al, 2014, Molecules CrossRef
5. Temozolomide induces autophagy in primary and established glioblastoma cells in an EGFR independent manner
   Silvia Würstle et al, 2017, Oncology Letters CrossRef
6. Drugging Hijacked Kinase Pathways in Pediatric Oncology: Opportunities and Current Scenario
   Marina Ferreira Candido et al, 2023, Pharmaceutics CrossRef
7. Metformin inhibits leptin-induced growth and migration of glioblastoma cells
   RITA FERLA et al, 2012, Oncology Letters CrossRef
8. New Chemical Scaffolds for Human African Trypanosomiasis Lead Discovery from a Screen of Tyrosine Kinase Inhibitor Drugs
   Ranjan Behera et al, 2014, Antimicrobial Agents and Chemotherapy CrossRef